YHYonghua Huang

Yonghua Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yonghua Huang has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Caffeine and modafinil counteract sleep deprivation through distinct neurocognitive pathways: an ERP study of object working memory

    by Yongcong Shao, Lin Xu, Xin An, Jingwei Zhang, Hongyang Xie, Jingjing Gong, Haishui Duan, Yonghua Huang

    Background: Sleep deprivation impairs core cognitive functions, such as working memory. Previous studies focused on global working memory performance, and direct comparisons of how different cognitive enhancers mitigate sleep deprivation-induced deficits in object working memory remain limited, particularly regarding the underlying neurophysiological mechanisms. This study compared the counteractive effects of caffeine and modafinil after 36 h of total sleep deprivation and elucidated their stage-specific neural mechanisms during object working memory processing. Methods: A randomized, double-blind, crossover design was used with 14 healthy male participants. Participants completed a 2-back object working memory task at baseline and after 36 h of sleep deprivation under caffeine and modafinil conditions. Event-related potentials were recorded to assess key component changes, including P2, N2, P3, and LPC. Results: Behaviorally, modafinil significantly improved accuracy after sleep deprivation, surpassing baseline performance, with an exploratory trend toward shorter reaction times. In contrast, caffeine maintained behavioral performance at baseline levels without significant change. Neurophysiologically, caffeine markedly increased P2 amplitude but significantly decreased LPC amplitude after sleep deprivation, reflecting enhanced early perceptual processing alongside a decline in late-stage cognitive maintenance resources. However, modafinil stabilized P2 and LPC responses, suggesting improved neural efficiency and sustained top-down cognitive control during stimulus evaluation. Conclusion: Although caffeine and modafinil mitigate sleep deprivation induced decline in object working memory, they operate through distinct neural mechanisms. Caffeine relies on generalized compensatory arousal mechanisms, whereas modafinil exerts a more efficient and targeted enhancement of executive control. These findings provide electrophysiological evidence supporting the differential application of cognitive enhancers under extreme sleep loss.

  • Open Access

    Nomogram prediction model for prognosis of patients with amyotrophic lateral sclerosis

    by Qionghua Sun, Hongfen Wang, Guochao Deng, Yuguo Du, Tie Ma, Jichao Ding, Zhenxi Xia, Yuqing Jiang, Yonghua Huang, Xusheng Huang

    Objectives: To analyze the factors affecting prognosis of patients with sporadic amyotrophic lateral sclerosis (ALS), to establish a nomogram predictive model. Methods: A total of 236 patients with sporadic ALS hospitalized in the Department of Neurology of the First Medical Center, Chinese PLA General Hospital, from March 2011 to November 2021 were enrolled in the study. Basic information and clinical and laboratory data of patients were collected, including sex, age at onset, body mass index, disease duration, diagnostic grade, and serum levels of creatine kinase (CK), creatinine (Cr), uric acid (UA), and ferritin. Kaplan-Meier univariate and multivariate Cox proportional hazard regression models were used to analyze the prognostic factors, and a nomogram predictive model was established. Results: Univariate analysis showed that ferritin, CK, Cr, age at onset, disease duration, and body mass index (BMI) were all correlated with prognosis of ALS. Multivariate analysis showed that ferritin, Cr, disease duration, age at onset, and BMI were the strongest predictors. ROC curve and correction curve analyses verified the accuracy of the nomogram prediction model. Conclusions: Ferritin, Cr, disease duration, age at onset, and BMI are independent predictors of survival in patients with ALS. Based on these clinical and biological prognostic factors, we established a quantitative model for predicting survival probability, and may assist in the prognostic evaluation of ALS, pending further validation.

  • Open Access

    Association Between Polypharmacy and Gait Performance in Older Adults With Cerebral Small Vessel Disease

    by Wei Wei, Hong-Yang Xie, Cui-Qiao Xia, Nan Zhang, Jun-Jie Cao, Hong-Yi Zhao, Yong-Hua Huang

    Background: The practice of polypharmacy is prevalent among older adults and has been associated with mobility decline and cognitive impairment. However, its effects on gait performance in patients with cerebral small vessel disease (CSVD)—a population inherently vulnerable to gait disturbances—remain poorly understood. This study investigated the impact of polypharmacy on gait performance during single-task walking (STW) and dual-task walking (DTW) in patients with CSVD, and identified neuroimaging correlates associated with polypharmacy. Methods: A total of 126 hospitalized individuals with CSVD were recruited. Based on the number of regularly used medications that had been in use for ≥2 weeks, patients were classified into three groups: non-polypharmacy (≤4 drugs, n = 47), polypharmacy (5–9 drugs, n = 49), or hyper-polypharmacy groups (≥10 drugs, n = 30). Gait speed and its coefficient of variation (CV) were recorded during STW and DTW. Magnetic resonance imaging was used to evaluate white-matter hyperintensities, lacunar infarcts, and cerebral microbleeds, which were integrated into a total CSVD burden score (0–3). Results: During STW, the hyper-polypharmacy group had significantly slower gait speed (0.70 ± 0.20 m/s) compared to the non-polypharmacy and polypharmacy groups (both >0.91 m/s, p < 0.001). In DTW, gait speed decreased and CV increased across all groups, with the most pronounced impairments in the hyper-polypharmacy group (DTW speed: 0.59 ± 0.15 m/s; CV: 16.03%). Linear regression revealed that medication count was negatively associated with gait speed (STW β = –5.622, p < 0.001; DTW β = –8.484, p < 0.001) and positively with gait variability during DTW (β = 0.246, p < 0.001). The total CSVD score was independently associated with polypharmacy (p = 0.036). Conclusion: The study confirmed a relationship between polypharmacy and locomotion in CSVD patients. Furthermore, total CSVD score—but not any single neuroimaging biomarker—is independently associated with the presence of polypharmacy.

  • Open Access

    Association of oral frailty and gait characteristics in patients with cerebral small vessel disease

    by Hong-Yang Xie, Jun-Li Chen, Cui-Qiao Xia, Nan Zhang, Zhen-Xi Xia, Hong-Yi Zhao, Yong-Hua Huang

    The objectives of this study were twofold: (1) to compare gait characteristics between cerebral small vessel disease (CSVD) patients with low-risk oral frailty (OF) and high-risk OF, particularly during dual-task walking (DTW); (2) to investigate the association of OF, the gait characteristics of DTW, and falls among older adults patients with CSVD. A total of 126 hospitalized patients diagnosed with CSVD were recruited and classified into a low-risk group (n = 90) and a high-risk group (n = 36) based on OF status in our study. Comprehensive data pertaining to basic parameters (cadence, as well as stride time, velocity and length), variability, asymmetry, and coordination were gathered during both single-task walking (STW) and DTW. Additionally, the number of falls was calculated. Subsequently, t-test or chi-squared test was used for comparison between the two groups. Furthermore, linear regression analysis was employed to elucidate the association of the OF index-8 score and gait parameters during cognitive DTW. Also, logistic regression models were utilized to assess the independent association of OF risk and falls. During cognitive DTW, the high-risk group demonstrated inferior performance in terms of basic parameters (p < 0.01), coefficient of variation (CV) of velocity and stride length (p < 0.05), as well as phase coordination index (PCI) when compared with the low-risk group (p < 0.05). Notably, differences in basic gait parameters were observed in cognitive DTW and STW conditions between the two groups (p < 0.01). However, only the high-risk group evinced significant variations in CV and PCI during cognitive DTW, as opposed to those during STW (p < 0.05). Furthermore, our findings also revealed the association of OF, the gait characteristics of cognitive DTW, (p < 0.01) and falls (p < 0.05). CSVD patients with a high risk of OF need to pay more attention to their gait variability or coordination. Also, they are recommended to undergo training involving dual-task activities while walking in daily life, thereby reducing the deterioration and mitigating the risk of falls. Besides, this study has confirmed an association of OF and DTW gait as well as falls in patients with CSVD.


  • Relationship between Body Composition and Gait Characteristics in Patients with Cerebral Small Vessel Disease

    by Hongyang Xie, Zhenxi Xia, Cuiqiao Xia, Nan Zhang, Yu Ding, Hongyi Zhao, Yonghua Huang

    Background: This study aims to explore the correlation between body composition, encompassing factors such as muscle mass and fat distribution, and gait performance during both single-task walking (STW) and dual-task walking (DTW) in patients diagnosed with cerebral small vessel disease (CSVD). Methods: The data of hospitalized patients diagnosed with CSVD, including cadence, stride time, velocity and stride length, as well as information on variability, asymmetry and coordination during both STW and DTW, were assessed. The number of falls reported by each participant was also assessed. Results: A total of 95 CSVD patients were assessed, and the results showed that individuals with low appendicular skeletal muscle mass (ASM), which includes both the low ASM group and the combination of low ASM and high body fat (BF) group, had reduced velocity or cadence, shortened stride length, and prolonged stride time across all walking modalities compared to the control group. Only the combination of the low ASM and high BF group exhibited a deterioration in the coefficient of variation (CV) for all basic parameters and the Phase Coordination Index (PCI) compared to the control group across all walking patterns. Conversely, patients in the high BF group displayed a decline in basic parameters, primarily during cognitive DTW. Concurrently, the high BF group showed a significant increase in the CV and the PCI compared to the control group only during cognitive DTW. Furthermore, regardless of gender, both ASM and BF independently correlated with the occurrence of falls. Conclusions: CSVD patients with varying body compositions could allocate different levels of attention to their daily walking routines.

  • Open Access

    The clinical characteristics of cerebral small vessel disease patients with motoric cognitive risk syndrome during single- and dual-task walking

    by Hongyang Xie, Nan Zhang, Cuiqiao Xia, Yu Ding, Hongyi Zhao, Yonghua Huang


  • Open Access

    Spatiotemporal gait characteristics during single- and dual-task walking are associated with the burden of cerebral small vessel disease

    by Cuiqiao Xia, Hongyang Xie, Tianjiao Li, Yu Ding, Hóngyi Zhào, Yonghua Huang

    Introduction: Gait impairment is a common symptom among individuals with cerebral small vessel disease (CSVD). However, performance differences between single-task walking (STW) and dual-task walking (DTW) among individuals with CSVD remain unclear. Therefore, we aimed to examine differences in gait characteristics during STW and DTW as well as the association between gait performance and neuroimaging markers.Methods: We enrolled 126 older individuals with CSVD. The speed, cadence, stride length, stride time, and their dual-task cost (DTC) or variability were measured under the STW, motor-cognitive DTW (cognitive DTW), and motor-motor DTW (motor DTW) conditions. We examined neuroimaging features such as white matter hyperintensities (WMHs), lacunes, microbleeds, and total burden. Further, we analysed the association of neuroimaging markers with gait performance, including gait variability and DTC.Results: Almost all spatiotemporal characteristics, as well as their DTCs or variabilities, showed significant among-group differences according to disease severity in the cognitive DTW condition; however, relatively lesser differences were observed in the STW and motor DTW conditions. The total CSVD burden score was moderately correlated with all the spatial parameters, as well as their DTCs or variabilities, in the cognitive DTW condition. Moreover, WMHs showed a correlation with speed, stride time, and cadence, as well as their DTCs, in the cognitive DTW condition. Furthermore, lacunes showed a moderate correlation with speed, stride length, and the DTC of speed, whilst microbleeds were only related to the DTC of stride length in the cognitive DTW condition. Neuroimaging biomarkers were not correlated with spatiotemporal parameters in STW and motor DTW conditions after Bonferroni correction. Moreover, the correlation coefficient between the total CSVD burden score and gait parameters was greater than those of other biomarkers.Discussion: Parameters in the cognitive DTW condition are more appropriate than those in the motor DTW condition for the evaluation of gait abnormalities in patients with CSVD. Moreover, the total CSVD burden score might have better predictive utility than any single neuroimaging marker. Patients with CSVD, especially those with moderate-to-severe disease, should concentrate more on their gait patterns and reduce the load of secondary cognitive tasks whilst walking in daily life.


  • Open Access

    Prognostic analysis of atrial fibrillation patients with acute cerebral infarction: a retrospective study of 330 cases over a 10-year period

    by Hai-Xia Wang, Nan Zhang, Guo-Qiang Wang, Yong-Hua Huang

    Background: The neurologic outcome of atrial fibrillation (AF) patients with acute ischemic stroke (AIS) is usually worse than those without AF. The aim of our study was to evaluate prognostic factors in AF-AIS. Methods We retrospectively collected information about AF-AIS patients admitted to our department from Jan. 2013 and Aug. 2023. According to the modified Rankin Scale (mRS) score at discharge, patients were divided into two groups: group A with favorable outcomes (mRS ≤ 2,) and group B with poor outcomes (mRS > 2). Results A total of 330 AF-AIS patients met the inclusion criteria, including 95 in group A and 235 in group B. The large-, medium- and small-infarct sizes were 45.5%, 31.5% and 23.0%, respectively. Intravenous alteplase thrombolysis (IV-rtPA) was prescribed to 69 patients. Parenchymal hemorrhage (PH) was present in 53 (16.1%) patients. The incidence of PH for patients with IV-rtPA was 34.8% (24/69), and 17.9% (45/251) for no-IV-rtPA patients. In univariate analysis, older age, higher NIHSS score and glucose, lower level of triglyceride, lager infarct size and PH were all associated with a poor outcome. No difference was found between the good and poor outcomes with IV-rtPA (18.9% vs. 21.7%, p = 0.578). In multivariate analysis, age (OR 1.059, 95% CI 1.024–1.094, p = 0.001), NIHSS score (OR 1.305, 95% CI 1.210–1.407, p < 0.001), infarct size (OR 2.485, 95% CI 1.018–6.062, p = 0.045), glucose (OR 1.994, 95% CI 1.011–3.933, p = 0.046) and PH (OR 4.130, 95% CI 1.303–13.092, p = 0.016) were independently associated with poor outcome. And, large infarct size (OR 3.786, 95% CI 1.912–7.459, p < 0.001), IV-rtPA (OR 4.904, 95% CI 2.452–9.808, p < 0.001), lower baseline level of triglyceride (OR 3.797, 95% CI 1.636–8.817, p = 0.002) and diabetes mellitus (OR 2.973, 95% CI 1.477–5.983, p = 0.002) were significantly associated with the development of PH. Conclusion The majority of AF-AIS patients had a poor outcome, which was independently associated with age, NIHSS score, infarct size, glucose and PH. IV-rtPA was related to an increased risk of PH and failed to improve overall short-term outcomes, especially for those with a large infarct size, a lower level of baseline triglyceride and a history of diabetes mellitus.

  • Open Access

    Spatiotemporal gait characteristics during single- and dual-task walking are associated with the burden of cerebral small vessel disease

    by Cuiqiao Xia, Hongyang Xie, Tianjiao Li, Yu Ding, Yonghua Huang, Hóngyi Zhào

    Background Gait impairment is common in patients with cerebral small vessel disease (CSVD). White matter lesions, lacunar infarction and cerebral microbleeds are typical neuroimaging markers of CSVD. However, few analyses have discussed discrepancies in CSVD patients during single-task walking (STW) and dual-task walking (DTW). Therefore, we aimed to examine the gait characteristics of CSVD patients during STW and DTW and to investigate the association between gait performance and neuroimaging markers. Methods We enrolled 126 elderly patients with CSVD and 30 healthy elderly as controls. The spatiotemporal gait parameters of the participants were measured under STW, motor-cognitive DTW (cognitive DTW), and motor-motor DTW (motor DTW) conditions. Neuroimaging features were examined, and the burden of disease was calculated. The association between neuroimaging markers and gait performance was analysed, as was the dual-task cost (DTC). Results Conventional cognitive function and measurements of STW did not reveal any obvious difference between the control and CSVD groups. However, all spatiotemporal variables and DTC of DTW revealed significant differences between the control and CSVD groups. Furthermore, there was little significant difference in traditional cognitive function or gait parameters during STW or motor DTW according to disease severity. However, spatiotemporal characteristics and DTC during cognitive DTW revealed significant differences among the three disability groups. The total CSVD burden score and white matter hyperintensities (WMHs) were negatively correlated with spatial parameters in the STW and motor DTW conditions. All neuroimaging biomarkers, except cerebral microbleeds, were correlated with all spatiotemporal parameters and DTC during cognitive DTW. The correlation coefficient of the total CSVD burden score was greater than those of the other markers. All gait performance deteriorated during cognitive DTW compared to STW. During motor DTW, only velocity and stride length showed marked reductions. For all parameters, the DTC of cognitive DTW was greater than that of motor DTW. Conclusions The DTW condition was associated with poorer gait performance than the STW condition. Moreover, cognitive DTW was more relevant than motor DTW for the evaluation of gait abnormalities in elderly patients with CSVD. In addition, the severity of neuroimaging lesions strongly affected gait characteristics, especially in cognitive DTW. The total CSVD burden score might have better predictive validity than any single neuroimaging marker.

  • Open Access

    Influences of blood lipids on the occurrence and prognosis of hemorrhagic transformation after acute cerebral infarction: a case-control study of 732 patients

    by Gang Lv, Guo-Qiang Wang, Zhen-Xi Xia, Hai-Xia Wang, Nan Liu, Wei Wei, Yong-Hua Huang, Wei-Wei Zhang